Q
QNCX//CIK 0001662774
Quince Therapeutics, Inc.
Market Data
$0.12−$3.19 (−96.37%)
QNCX · Last trade
Prev Close
$3.31
Range (31d)
$0.12 – $3.31
Recent Filings
- 8-K156.0 KBQuince Therapeutics, Inc.Feb 12, 6:06 AM ET·0001193125-26-047544
- 8-K135.4 KBQuince Therapeutics, Inc.Feb 2, 4:30 PM ET·0001193125-26-033758
- 8-K169.1 KBQuince Therapeutics, Inc.Jan 29, 4:40 PM ET·0001193125-26-029524
- 10-Q12.8 MBQuince Therapeutics, Inc.Nov 12, 11:05 AM ET·0001193125-25-277529
- 8-K477.1 KBQuince Therapeutics, Inc.Nov 12, 11:05 AM ET·0001193125-25-277523
- 8-K138.8 KBQuince Therapeutics, Inc.Oct 17, 4:11 PM ET·0001193125-25-242514
- 8-K138.8 KBQuince Therapeutics, Inc.Sep 26, 4:45 PM ET·0001193125-25-220722
- 10-Q12.7 MBQuince Therapeutics, Inc.Aug 11, 4:06 PM ET·0000950170-25-106535
- 8-K456.9 KBQuince Therapeutics, Inc.Aug 11, 4:05 PM ET·0000950170-25-106536
- 8-K186.8 KBQuince Therapeutics, Inc.Jul 16, 4:30 PM ET·0001193125-25-159886
Insiders
10- Benatti LucaDirector
- Boeding Chad10% Owner
- Bray JuneDirector
- Detke Michael J.Chief Medical Officer
- Dominy Stephen S.Director, Chief Scientific Officer
- EPIQ Capital Group, LLCIA/Managing Member 10% owner
- Gafric KristenSVP, Legal & Administration
- Hannah BrendanCBO, COO & CCO
- Holsinger LeslieExecutive Vice President
- Janhofer GuenterChief Scientific Officer
Tickers
Addresses
business
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO, CA, 94080
mailing
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- Cortexyme, Inc.2022-08-01